OhioLINK has negotiated an upgraded agreement that offers open-access publishing benefits. Starting in January 2024 and continuing through the end of 2027, authors at participating OhioLINK member institutions now have the ability to publish open access (OA) journal articles in most of Elsevier’s hybrid journals at no additional cost to either the author or the institution. Some journals are excluded from open-access publishing benefits, such as Cell Press and Lancet journals.
Author queries: oasupport@elsevier.com